Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP641121.RAmrKa_klTf_RPKasINHk_1IZTOAbJQ1HgxY-hLyXN7Pk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP641121.RAmrKa_klTf_RPKasINHk_1IZTOAbJQ1HgxY-hLyXN7Pk130_assertion type Assertion NP641121.RAmrKa_klTf_RPKasINHk_1IZTOAbJQ1HgxY-hLyXN7Pk130_head.
- NP641121.RAmrKa_klTf_RPKasINHk_1IZTOAbJQ1HgxY-hLyXN7Pk130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641121.RAmrKa_klTf_RPKasINHk_1IZTOAbJQ1HgxY-hLyXN7Pk130_provenance.
- NP641121.RAmrKa_klTf_RPKasINHk_1IZTOAbJQ1HgxY-hLyXN7Pk130_assertion evidence source_evidence_literature NP641121.RAmrKa_klTf_RPKasINHk_1IZTOAbJQ1HgxY-hLyXN7Pk130_provenance.
- NP641121.RAmrKa_klTf_RPKasINHk_1IZTOAbJQ1HgxY-hLyXN7Pk130_assertion SIO_000772 18024656 NP641121.RAmrKa_klTf_RPKasINHk_1IZTOAbJQ1HgxY-hLyXN7Pk130_provenance.
- NP641121.RAmrKa_klTf_RPKasINHk_1IZTOAbJQ1HgxY-hLyXN7Pk130_assertion wasDerivedFrom befree-2016 NP641121.RAmrKa_klTf_RPKasINHk_1IZTOAbJQ1HgxY-hLyXN7Pk130_provenance.
- NP641121.RAmrKa_klTf_RPKasINHk_1IZTOAbJQ1HgxY-hLyXN7Pk130_assertion wasGeneratedBy ECO_0000203 NP641121.RAmrKa_klTf_RPKasINHk_1IZTOAbJQ1HgxY-hLyXN7Pk130_provenance.